serous carcinoma造句

• Serous carcinomas are thought to develop from endometrial intraepithelial carcinoma.
• Cancer in a serous cavity is called a serous carcinoma.
• Serous carcinoma of the ovaries has been related to a missense mutation S6F.
• Low-grade serous carcinomas of the ovary contain very few point mutations.
• Type II cancers are of higher histological grade and include serous carcinoma and carcinosarcoma.
• Serous carcinomas may develop from serous tubal intraepithelial carcinoma, rather than developing spontaneously from ovarian tissue.
• P53 mutations and chromosome instability are associated with serous carcinomas, which tend to resemble ovarian and Fallopian carcinomas.
• Papillary serous carcinoma, clear cell carcinoma, and endometrioid carcinoma are the subtypes at the highest risk of recurrence.
• Like uterine papillary serous carcinoma CC does not develop from endometrial hyperplasia and is not hormone sensitive, rather it arises from an atrophic endometrium.
• Technically a  serous carcinoma can occur anywhere on these membranes, but high-grade serous carcinoma is generally limited to the peritoneal area.
• 50 % of the time, serous carcinomas are bilateral, and in 85 % of cases, they have spread beyond the ovary at the time of diagnosis.
• If glands are seen to fuse with intricate, extensive papillae featuring epithelial tufting with solid nests surrounded by a space alongside irregular slit-like spaces, then serous carcinoma is suspected.
• ARID1A, which often carries a point mutation in Type I endometrial cancer, is also mutated in 26 % of clear cell carcinomas of the endometrium, and 18 % of serous carcinomas.
• Using immunohistochemistry, WT1 protein can be demonstrated in the cell nuclei of 75 % of mesotheliomas and in 93 % of ovarian serous carcinomas, as well as in benign mesothelium and fallopian tube epithelium.
• HGSC is distinct from low-grade serous carcinoma ( LGSC ) which arises from ovarian tissue, is less aggressive and is present in stage I ovarian cancer where tumours are localised to the ovary.
• Histomorphological and molecular biological characteristics suggest that serous carcinomas, which include ovarian serous carcinoma, uterine serous carcinoma, Fallopian tube serous carcinoma, cervical serous carcinoma, and primary peritoneal serous carcinoma really represent one entity.
• Histomorphological and molecular biological characteristics suggest that serous carcinomas, which include ovarian serous carcinoma, uterine serous carcinoma, Fallopian tube serous carcinoma, cervical serous carcinoma, and primary peritoneal serous carcinoma really represent one entity.
• Histomorphological and molecular biological characteristics suggest that serous carcinomas, which include ovarian serous carcinoma, uterine serous carcinoma, Fallopian tube serous carcinoma, cervical serous carcinoma, and primary peritoneal serous carcinoma really represent one entity.
• Histomorphological and molecular biological characteristics suggest that serous carcinomas, which include ovarian serous carcinoma, uterine serous carcinoma, Fallopian tube serous carcinoma, cervical serous carcinoma, and primary peritoneal serous carcinoma really represent one entity.
• Histomorphological and molecular biological characteristics suggest that serous carcinomas, which include ovarian serous carcinoma, uterine serous carcinoma, Fallopian tube serous carcinoma, cervical serous carcinoma, and primary peritoneal serous carcinoma really represent one entity.